Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Typesort descending Therapeutic or Technology Institution Stage Project Objective Details
Stroke Embryonic Stem Cell Donor cell therapy UCLA
Pre-IND/IDE or Equivalent
COVID-19 Embryonic Stem Cell,
iPS Cell
Gene-modified, donor cell therapy COH
Proof of Concept
Liver Disease iPS Cell Diagnostic Test UCSF
Development Candidate, Proof of Concept
COVID-19 iPS Cell Model system development UC Berkeley
Proof of Concept
Heart failure iPS Cell Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Bladder or Urinary Tract Disorder,
Incontinence
iPS Cell Personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Angelman Syndrome,
Autism
iPS Cell Gene Therapy, cell free UC Davis
Development Candidate, Proof of Concept
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Heart Disease iPS Cell Model system development Stanford
Development Candidate, Proof of Concept
Intestinal Disease,
Neurological Disorders
iPS Cell Donor cell therapy CHLA
Pre-IND/IDE or Equivalent
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Canavan Disease iPS Cell Gene-modified, personalized cell therapy COH
Pre-IND/IDE or Equivalent
Dementia iPS Cell Donor cell therapy Gladstone
Development Candidate, Proof of Concept
Vision Loss iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Amyotrophic Lateral Sclerosis iPS Cell Nucleic acid based therapy USC
Development Candidate, Proof of Concept
Liver Disease iPS Cell Gene-modified, donor cell therapy CHLA
Development Candidate, Proof of Concept
Traumatic Brain Injury iPS Cell Donor cell therapy UC Irvine
Development Candidate, Research Insights
Stroke iPS Cell Donor cell therapy UCLA
Development Candidate, Proof of Concept
Heart Disease iPS Cell Donor cell therapy UC Davis
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy Sanford-Burnham
Development Candidate, Proof of Concept
COVID-19 iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Retinitis Pigmentosa Other Donor cell therapy jCyte
Clinical Trial, Phase 2
Brain Cancer Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Metabolic Disorders Somatic Cell Gene-modified, personalized cell therapy Immusoft Corporation
Pre-IND/IDE or Equivalent
Duchenne Muscular Dystrophy Somatic Cell Gene Therapy, cell free MyoGene Bio LLC
Pre-IND/IDE or Equivalent
B cell cancers Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Brain Cancer Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Parkinson's Disease Vital Research Opportunity Gene Therapy, cell free Brain Neurotherapy Bio
Clinical Trial, Phase 1 or Phase 1/2
COVID-19,
Respiratory Disorders
Other,
Vital Research Opportunity
Convalescent Plasma COH
Research Insights
IPEX Syndrome,
Immune Disease
Vital Research Opportunity Gene Therapy, cell free Stanford
IND

Pages

Icon for csv export